| BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2010 (Business Wire) ELMWOOD PARK, N.J.----BioReference Laboratories, Inc. announced today it plans to issue earnings results for the second quarter of fiscal 2010 before the open of market trading on Thursday, May 27, 2010. us.rd.yahoo.com |
Novartis: Gilenia Clears Latest Regulatory Hurdle With Ease EP Vantage submits:The phrase "medical breakthrough" is often overused and misplaced, but in Gilenia’s (fingolimod) case this is truly appropriate as it is on the verge of becoming the first oral drug to treat MS patients, up to 40% of whom are estimated to delay or refuse initial treatment with currently available injectable agents.An FDA advisory committee yesterday issued a surprisingly unanimous recommendation to approve the Novartis (NVS) drug, although the Swiss group is likely to keep celebrations on ice until formal approval is granted in September given the regulator’s recent unpredictability; InterMune’s (ITMN) experience with pirfenidone bears testimony to this. The committee votes were surprising, given safety concerns with the drug and the fact that approval as a first line therapy was also strongly endorsed (Event – Gilenia’s safety the main focus of advisory committee, June 7, 2010). Novartis’ shares gained 3% today to SFr55.55 as multiple analysts announced major upgrades to their Gilenia forecasts, current consensus for which sits at $952m by 2016.Complete Story » seekingalpha.com |
Cadence Pharmaceuticals Inc. Q2 2010 Earnings Call Transcript Cadence Pharmaceuticals Inc. (CADX)Q2 2010 Earnings CallAugust 05, 2010Complete Story » seekingalpha.com |
Theaters, Planes to Post Calories The federal government plans to expand posted calorie counts beyond restaurants to include thousands of other places that offer food, including airplanes, movie theaters and convenience stores. online.wsj.com |
Clarient, Inc. Shareholder Investigation by Briscoe Law Firm Regarding the Buyout by General Electric Company [Business Wire] - The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Powers Taylor, LLP are investigating potential legal claims against the Board of Directors of Clarient, Inc. related to the proposed buy-out of Clarient by General Electric Company. us.rd.yahoo.com |